Arquivamento definitivo - Art. 33 da LPI
#11.1.1
01/17/2023
RPI 2715
Application data
Number
112021000882Type
Filing
Publication
PCT
US2019042919 The application was abandoned: examination was not requested within the 36 months following the 07/23/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 01/17/2023. We update with every new RPI gazette, published weekly.
Applicants
RAFAEL PHARMACEUTICALS, INC.
US
Inventors
R. S. (pessoa física)
US
S. L. (pessoa física)
US
IPC Classification
Priority claims
US
62/701,993 · 07/23/2018
US
62/782,938 · 12/20/2018
US
62/834,470 · 04/16/2019
Abstract
A invenção fornece métodos, composições e kits médicos para o tratamento de câncer pancreático usando (i) ácido 6,8-bis(benzilsulfanil)octanoico ou um sal farmaceuticamente aceitável do mesmo em combinação com (ii) gencitabina ou um sal farmaceuticamente aceitável do mesmo, e (iii) nab-paclitaxel.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
01/17/2023
RPI 2715
#11.1
11/01/2022
RPI 2704
#1.3
04/13/2021
RPI 2623
#1.1
01/26/2021
RPI 2612
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.